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ABSTRACT
Background Early pulmonary rehabilitation after 
exacerbation of chronic obstructive pulmonary disease 
(COPD) has previously been shown to reduce the risk of 
hospital admission and improve physical performance and 
quality of life. However, the impact of attendance at early 
rehabilitation programmes has not been established.
Objectives To evaluate the impact of increasing attendance 
to pulmonary rehabilitation on the risk of hospital admission, 
physical performance and quality of life in patients attending 
an early rehabilitation programme after an exacerbation of 
COPD.
Methods This study was a secondary exploratory analysis 
of the randomised controlled trial COPD- EXA- REHAB study, 
involving patients hospitalised with an exacerbation of COPD. 
The COPD- EXA- REHAB study compared early pulmonary 
rehabilitation, starting within 2 weeks after an exacerbation, 
with standard treatment, that is, the same programme 
starting 2 months later. The present analysis included only 
the 70 patients allocated to early pulmonary rehabilitation.
Results At 1- year follow- up, we found an association 
between the number of sessions attended and a reduction in 
hospital admissions (incidence rate ratio 0.93 (95% CI 0.88 
to 0.99), p=0.02), corresponding to a 7% reduction for each 
session attended. Similarly, at 2- month follow- up, physical 
performance was positively associated with sessions 
attended: the mean Incremental Shuttle Walk Test result 
improved by 8 m with each session (95% CI 2.54 to 13.56, 
p=0.005) and the Endurance Shuttle Walk Test result by 44 
s (95% CI 18.41 to 68.95, p=0.001). Quality of life, assessed 
using the COPD Assessment Test, was not significantly 
associated with the number of attended sessions, with the 
average score increasing by 0.15 points with each session 
(95% CI −0.35 to 0.65, p=0.55).
Conclusion Increased attendance at early pulmonary 
rehabilitation after exacerbation of COPD was associated with 
reduced risk of hospital admission and improved physical 
performance.
BACKGROUND
Pulmonary rehabilitation in patients with 
chronic obstructive pulmonary disease 
(COPD) is a comprehensive interven-
tion comprising supervised exercise and 
education, which increases physical perfor-
mance, reduces symptoms and improves 
quality of life.1 2 In addition, increasing 
evidence suggests that early pulmonary 
rehabilitation following acute exacerbation 
of COPD has a beneficial effect on hospital 
admission and mortality.3 4 As a result of 
the evidence for these positive effects, early 
pulmonary rehabilitation is highly recom-
mended in most guidelines for the manage-
ment of patients with COPD.5 6
However, adherence to the rehabilitation 
programme in stable COPD is low.7 8 Up to 
50% of the patients referred to rehabilita-
tion never attend a single session.9 Factors 
that influence non- participation in pulmo-
nary rehabilitation may be environmental, 
such as long travel distance and transport 
issues, social factors such as lack of support 
from family and friends, or lack of perceived 
benefit from rehabilitation.10 11 Other factors 
associated with poorer adherence to rehabil-
itation include current smoking, low quality 
of life, anxiety and depression.12 Although 
Key messages
What is the key question?
 ► How does attendance impact the effect of early pul-
monary rehabilitation after exacerbation of chronic 
obstructive pulmonary disease (COPD)?
What is the bottom line?
 ► Increasing attendance is associated with improved 
benefit of early pulmonary rehabilitation.
Why read on?
 ► This post hoc analysis provides evidence that in-
creased attendance at early pulmonary rehabilita-
tion after exacerbation of COPD is associated with 
reduced risk of hospital admission and improved 
physical performance.
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the potential benefits of early pulmonary rehabilitation 
following an exacerbation are greater than in stable 
COPD, similar problems exist regarding adherence. A 
UK audit on early pulmonary rehabilitation reported 
that only 48% of the referred patients completed the 
rehabilitation programme, and similar results have been 
found in other trials.13 14 It is assumed that poor atten-
dance may have a negative influence on the effect of 
early pulmonary rehabilitation in COPD, but this needs 
to be confirmed.
In our previous randomised controlled trial (RCT) 
study, COPD- EXA- REHAB, we compared the efficacy of 
early REHABilitation starting within 2 weeks following 
an EXAcerbation versus late pulmonary rehabilitation 
that started 2 months after an exacerbation of COPD. 
Although adherence in the early rehabilitation group was 
significantly higher than in the late rehabilitation group, 
it was still only 56%.15
In the present exploratory study, we therefore anal-
ysed the impact of attendance at an early rehabilitation 
programme shortly after a hospitalisation for an exacer-
bation on hospital readmission, physical performance 
and quality of life.
METHODS
Study design
This study was a subgroup analysis of the COPD- EXA- 
REHAB study, which was an investigator- initiated, 
randomised, single- centre, open- label clinical trial in 
patients hospitalised with an exacerbation of COPD. 
The patients were randomised either to early pulmonary 
rehabilitation within 2 weeks of discharge or to standard 
rehabilitation after 2 months in the stable phase. The 
ClinicalTrials. gov registry identifier was NCT02987439.
Study population
Eligible patients admitted with an acute exacerbation 
of COPD to the Department of Respiratory Medicine, 
Gentofte Hospital, from 2013 to 2016 were included. 
The inclusion criteria were hospital admission with acute 
exacerbation of COPD, a diagnosis of COPD, age >18 
years and capability to walk 10 m independently. Exclu-
sion criteria were the inability to provide written consent 
and understand Danish, estimated life expectancy of 
under 6 months due to other serious illnesses such as 
heart disease or cancer, participation in another reha-
bilitation programme, living in a nursing home and resi-
dence outside Gentofte Hospital’s recruitment area. The 
present analysis only included the patients in the early 
rehabilitation group.
Pulmonary rehabilitation programme
The pulmonary rehabilitation programme was a 7- week 
outpatient programme composed of twice- weekly one- 
and- a- half- hour supervised training sessions and weekly 
1 h multidisciplinary educational sessions, in accordance 
with the Danish Health Authority’s pulmonary reha-
bilitation guideline for patients with COPD.16 The 
training sessions were supervised by a physiotherapist 
and consisted of endurance and resistance training at 
moderate to high intensity (Borg scale of perceived exer-
tion (CR10) 4 to 7). The educational programme aimed 
to improve the patients’ management of their disease, 
maintenance of physical activity and exercise training 
at home, smoking cessation, use of medication, coping 
strategies, diet and handling of exacerbations.
Primary outcome
Risk of hospital admission within the 12- month study 
period.
Secondary outcomes
Increase in exercise performance, measured by the 
incremental shuttle walk test (ISWT) and endurance 
shuttle walk test (ESWT), and health- related quality of 
life, measured by the COPD Assessment Test (CAT) at 2 
months after inclusion, at the end of the rehabilitation 
programme. The ISWT is a test to measure maximal 
exercise performance. The ESWT measures submaximal 
exercise performance corresponding to 85% of VO2max 
calculated from the ISWT.
Statistical analysis
Baseline characteristics are presented as mean (and 
SDs) for parametric data and median (and IQR) for 
non- parametric data. Categorical data are presented as 
frequency and percentage. After checking for colline-
arity (r<0.70), we used backwards stepwise elimination 
for all baseline characteristics to retain variables in the 
multivariate models for the different outcomes (p<0.10). 
The primary outcome was analysed with negative bino-
mial regression, and sensitivity analysis using logistic 
regression was performed on the impact of adherence on 
hospital admissions. Adherence was defined as attending 
>75% of rehabilitation sessions, as in the original study 
paper.15 For the secondary outcomes, we used a general 
linear regression for the ISWT, ESWT and CAT. Statis-
tical significance was set at an alpha level of 0.05. The 
statistical analyses were performed using Stata V.13 (Stata 
Corporation, College Station, TX, USA).
RESULTS
Baseline
A total of 70 patients were allocated to early pulmonary 
rehabilitation. At inclusion, the patients were an average 
72.7 (9.4) years of age, predominantly women (59%, 41), 
with severe airflow limitation (mean FEV1 40.2%) and 
highly symptomatic (Medical Research Council breath-
lessness scale (MRC) 3.4 and CAT 16.8), which is repre-
sentative for a population of patients hospitalised with 
acute exacerbation of COPD in Denmark.17 Exercise 
capacities at baseline were 180 (IQR 100.0–240.0) m on 
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the ISWT and 159.0 (IQR 119.0–233.5) s on the ESWT. 
Table 1 presents the demographic data and baseline 
measures at the time of inclusion for all patients.
The median number of rehabilitation sessions the 
patients attended was 8.9. Twelve patients did not attend 
any rehabilitation sessions, 19 partially attended and 39 
met the a priori definition of adherence. Of the patients 
attending no rehabilitation sessions, three died before 
the programme commencement, two never began the 
programme for unknown reasons, and seven did not 
want to participate in the programme despite agreeing to 
the study and completing the informed consent.
Hospital readmissions
The median number of hospital admissions overall was 1 
(IQR 0–3) during the 12- month study period.
Modelling of the risk of hospitalisation showed that 
the crude incidence rate ratio (IRR) of admission was 
associated with the number of rehabilitation sessions 
the patient attended (IRR 0.93 (95% CI 0.88 to 0.99), 
p=0.018), corresponding to a reduction of 7% for each 
session. After elimination of covariates, age, FEV1, CAT 
and MRC were retained in the adjusted model. The 
inclusion of these variables in the model did not alter 
the estimate (IRR 0.93 (95% CI 0.88 to 0.99), p=0.020). 
Figure 1 illustrates the estimated risk of hospital admis-
sion according to the number of rehabilitation sessions 
the patients attended. The sensitivity analysis showed that 
adherence (attending at least 75% of the sessions) was 
highly associated with a reduction in hospital admissions 
(OR 0.14 (95% CI 0.03 to 0.56), p=0.006 adjusted for 
CAT and pack- years).
Secondary outcomes
The mean ISWT increased by 69 m (95% CI 43 to 95) 
at the completion of the rehabilitation programme, 2 
months after inclusion, which is higher than the minimal 
clinically important difference (MCID) for the ISWT of 
47.7 m.18 The univariate model showed a significant asso-
ciation between improvement in ISWT and the number 
of completed rehabilitation sessions, corresponding to 
an increase of 8 m for every rehabilitation session the 
patients attended (slope 8.05 m (95% CI 2.54 to 13.55), 
p=0.005). We tested for all baseline covariates (table 1), 
but after backwards elimination, no covariates were signif-
icant, so the multivariate model could not be performed.
The mean improvement in ESWT was 392 s (95% CI 
278 to 506) at the 2- month follow- up, which exceeds the 
MCID of 186 to 199 s.19 In addition, we found an associ-
ation between the number of completed rehabilitation 
sessions and the ESWT improvement, with an estimated 
increase of 44 s per attended session (slope 43.68 m (95% 
CI 18.41 to 68.95), p=0.001). The multivariate model 
showed similar results (slope 46.58 m (95% CI 26.65 to 
66.50), p=0.000), adjusted for pack- years and smoking 
status.
The mean change in CAT score for all patients was −3.6 
points (95% CI −5.4 to −1.7) at the 2- month follow- up. 
The MCID for CAT score in pulmonary rehabilitation is 
−2.0 points.20 No association was found between change 
in CAT score and the number of completed rehabilitation 
Table 1 Patient characteristics at baseline
Characteristics All patients
    
N   70
Age (years), mean (SD)   72.7 (9.4)
Sex, n (%) Male 29 (41%)
  Female 41 (59%)
FEV1 (litres), mean (SD)   1.0 (0.4)
FEV1 (% predicted), mean (SD)   40 (15)
MRC, mean (SD)   3.4 (0.9)
CAT, mean (SD)   16.8 (6.0)
Saturation without O2 supplement (%), 
mean (SD)
  1.0 (0.0)
Long- term oxygen therapy, n (%) No 63 (95%)
  Yes 3 (5%)
BMI (kg/m2), mean (SD)   23.5 (4.6)
Smoking status, n (%) Current 22 (31%)
Former 45 (64%)
Never 3 (4%)
Pack- years, mean (SD)   40.6 (16.5)
Leaving the house daily No 25 (38%)
  Yes 41 (62%)
ISWT (m), median (IQR)   180.0 (100.0–
240.0)
ESWT (s), median (IQR)   159.0 (119.0–
233.5)
ESWT level (pace), median (IQR)   6.0 (4.0–8.0)
BMI, body mass index; CAT, COPD Assessment Test; ESWT, 
endurance shuttle walk test; ISWT, incremental shuttle walk test; 
MRC, Medical Research Council dyspnoea scale.
Figure 1 Estimated risk of hospital admission according 
to number of rehabilitation sessions the patients attended. 
Incidence rate ratio 0.93 (95% CI 0.88 to 0.99), p=0.02.
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sessions in either the univariate model (slope 0.15 points 
(95% CI −0.35 to 0.65), p=0.55) or the adjusted model 
(slope −0.08 points (95% CI −0.46 to 0.30), p=0.68), 
adjusted for body mass index and CAT.
Both the crude and adjusted analysis for hospital 
admissions and secondary outcomes are shown in table 2.
DISCUSSION
In the present secondary analysis of the COPD- EXA- 
REHAB study, we focused on the importance of early 
pulmonary rehabilitation programme attendance 
following an acute exacerbation of COPD. We found that 
increased attendance was associated with a reduced risk 
of hospital admission. Improved physical performance 
assessed by walking tests was also associated with the 
number of completed sessions, whereas we did not find 
any association between attendance and quality of life as 
assessed by the CAT.
To the best of our knowledge, this is the first paper to 
investigate the association between the number of reha-
bilitation sessions attended and outcomes of early pulmo-
nary rehabilitation after an exacerbation of COPD.
A risk reduction corresponding to a reduction in 
hospital admissions of 7% per attended rehabilitation 
session is a considerable effect. We cannot conclude from 
the data that this is a causal effect, mainly because of the 
small size and risk of confounding. However, the asso-
ciation remained statistically significant in the adjusted 
models. The present analyses should be regarded as 
exploratory and the results should be confirmed in a 
prospective trial.
Several studies and reviews have shown a reduced 
risk of hospitalisation after early pulmonary rehabilita-
tion.21 However, a review by Moore et al included RCTs, 
non- randomised cohort studies, and studies comparing 
before and after rehabilitation.21 The original RCT 
COPD- EXA- REHAB study showed a non- significant 
reduction in hospital admissions in the early pulmonary 
rehabilitation group compared with the rehabilitation in 
stable phase group.15 The study participants resembled 
a general COPD population due to the wide inclusion 
criteria, which may explain the low adherence to the 
rehabilitation programme. The results of the present 
analysis show that increased attendance seems to reduce 
the risk of hospital admission, suggesting that low adher-
ence is a reason for the overall negative result of the 
RCT. This is in line with several studies on early pulmo-
nary rehabilitation showing reduced hospital admissions 
when compared with no rehabilitation, summed up in a 
2018 systematic review by Ryrsø et al.22
Seven patients in the COPD- EXA- REHAB study did 
not want to participate in the rehabilitation sessions, 
although they had read and signed the informed consent 
and underwent randomisation while admitted for their 
exacerbation. We did not register the reasons for their 
change of mind, and we were not allowed to check their 
medical charts after their drop- out. We know from other 
studies that one of the main reasons for not attending 
pulmonary rehabilitation after hospitalisation for a 
COPD exacerbation is that the patients do not feel well 
enough.14 23 A qualitative study of patients who refused 
pulmonary rehabilitation after exacerbation of COPD 
also found that some felt shame, self- blame, embarrass-
ment or that they were ‘not worthy’ of rehabilitation.24 
Healthcare professionals must consider these aspects 
when patients decline pulmonary rehabilitation shortly 
after an exacerbation. In a systematic review of interven-
tions to improve uptake and completion of pulmonary 
rehabilitation, only one randomised study was identified 
and showed no effect of the intervention, which used a 
tablet computer with instructions and a training diary 
in addition to pulmonary rehabilitation.25 26 This clearly 
illustrates the lack of evidence regarding interventions to 
improve adherence to pulmonary rehabilitation. There-
fore, a Cochrane review including a broad range of study 
designs is underway, aiming to determine effective inter-
ventions to improve uptake and adherence.27
We found a significant association between improved 
physical performance and attendance, which is in line with 
other studies comparing non- completers and completers 
of pulmonary rehabilitation.28 29 Although CAT scores 
improved significantly, we did not find a significant 
Table 2 Hospital admissions, physical performance and quality of life (adjusted analysis)
Unadjusted analysis Adjusted analysis
Estimate 95% CI P value Estimate 95% CI P value
Hospital admissions IRR 0.93 0.88 to 0.99 0.018 0.93 0.88 to 0.99 0.020
ISWT (m) Slope 8.05 2.54 to 13.56 0.005 NA
ESWT (s) Slope 43.68 18.41 to 68.95 0.001 46.58 26.65 to 66.50 0.000
CAT (points) Slope 0.15 −0.35 to 0.65 0.55 −0.08 −0.46 to 0.30 0.68
Hospital admissions at 12- month follow- up. ISWT, ESWT and CAT at 2- month follow- up. ISWT was not adjusted. ESWT was adjusted for 
pack- years and smoking status. CAT was adjusted for BMI and CAT at baseline. ISWT, ESWT and CAT were analysed with linear regression.
Hospital admissions were analysed with negative binomial regression and adjusted for age, FEV1, CAT and MRC at baseline.
Fit parameters for each model (McFadden’s R2): Hospital admissions: crude model R2=0.02 and adj. model R2=0.08. ISWT: crude model 
R2=0.12.ESWT: crude model R2=0.18 and adj. model R2=0.41. CAT:crude model R2=0.01 and adj model R2=0.30.
CAT, COPD Assessment Test; ESWT, endurance shuttle walk test; ISWT, incremental shuttle walk test; MRC, Medical Research Council 
dyspnoea scale; NA, not applicable.
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association between the quality of life measured by the 
CAT and rehabilitation programme attendance.
A potential limitation of this analysis is that we did not 
have the data on hospital admissions and exacerbations 
before inclusion in the study. Further, we did not have 
information on daily physical activity and maintenance 
training in the follow- up period. Lastly, the original 
COPD- EXA- REHAB study was a single- centre RCT, which 
may reduce the generalisability of the results.
CONCLUSION
We found early pulmonary rehabilitation after discharge 
from hospital following an exacerbation of COPD was 
associated with reduced risk of hospital readmission and 
enhanced physical performance. These results supple-
ment our knowledge of the positive effect of pulmonary 
rehabilitation shortly after exacerbation of COPD and 
emphasise the importance of improving rehabilitation 
programme attendance. However, these findings are 
exploratory and need to be confirmed in future, prospec-
tive studies.
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